$2.41T
Total marketcap
$72.96B
Total volume
BTC 50.62%     ETH 14.98%
Dominance

Hester Biosciences Limited HESTERBIO.NS Stock

1590 INR {{ price }} -0.025152% {{change_pct}}%
COUNTRY
India
Exchange
NSE
Market Cap
13.53B INR
LOW - HIGH [24H]
1564.35 - 1659 INR
VOLUME [24H]
6.59K INR
{{ volume }}
P/E Ratio
71.07
Earnings per share
22.37 INR

Hester Biosciences Limited Price Chart

Hester Biosciences Limited HESTERBIO.NS Financial and Trading Overview

Hester Biosciences Limited stock price 1590 INR
Previous Close 1628.85 INR
Open 1636.1 INR
Bid 1633.4 INR x 0
Ask 1635.15 INR x 0
Day's Range 1629.5 - 1651.9 INR
52 Week Range 1404.55 - 2450 INR
Volume 3.87K INR
Avg. Volume 4.53K INR
Market Cap 14.13B INR
Beta (5Y Monthly) 0.664041
PE Ratio (TTM) 50.23993
EPS (TTM) 22.37 INR
Forward Dividend & Yield 10 (0.61%)
Ex-Dividend Date August 11, 2022
1y Target Est N/A

HESTERBIO.NS Valuation Measures

Enterprise Value 13.75B INR
Trailing P/E 50.23993
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.023105
Price/Book (mrq) 3.936877
Enterprise Value/Revenue 4.887
Enterprise Value/EBITDA 20.902

Trading Information

Hester Biosciences Limited Stock Price History

Beta (5Y Monthly) 0.664041
52-Week Change -27.29%
S&P500 52-Week Change 20.43%
52 Week High 2450 INR
52 Week Low 1404.55 INR
50-Day Moving Average 1726.43 INR
200-Day Moving Average 1834.78 INR

HESTERBIO.NS Share Statistics

Avg. Volume (3 month) 4.53K INR
Avg. Daily Volume (10-Days) 3.65K INR
Shares Outstanding 8.51M
Float 2.46M
Short Ratio N/A
% Held by Insiders 63.37%
% Held by Institutions 0.44%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 8
Trailing Annual Dividend Yield 0.49%
5 Year Average Dividend Yield 52.00%
Payout Ratio 0.3034
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 9.46%
Operating Margin (ttm) 16.02%
Gross Margin 72.44%
EBITDA Margin 23.38%

Management Effectiveness

Return on Assets (ttm) 4.57%
Return on Equity (ttm) 10.08%

Income Statement

Revenue (ttm) 2.81B INR
Revenue Per Share (ttm) 348.13 INR
Quarterly Revenue Growth (yoy) 14.49%
Gross Profit (ttm) N/A
EBITDA 657.6M INR
Net Income Avi to Common (ttm) 266.27M INR
Diluted EPS (ttm) 32.51
Quarterly Earnings Growth (yoy) -41.29%

Balance Sheet

Total Cash (mrq) 148.17M INR
Total Cash Per Share (mrq) 21.98 INR
Total Debt (mrq) 2.74B INR
Total Debt/Equity (mrq) 95.01 INR
Current Ratio (mrq) 1.531
Book Value Per Share (mrq) 414.872

Cash Flow Statement

Operating Cash Flow (ttm) 235.96M INR
Levered Free Cash Flow (ttm) -514643744 INR

Profile of Hester Biosciences Limited

Country India
State N/A
City Ahmedabad
Address Pushpak
ZIP 380006
Phone 91 79 2644 5107
Website https://www.hester.in
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Q&A For Hester Biosciences Limited Stock

What is a current HESTERBIO.NS stock price?

Hester Biosciences Limited HESTERBIO.NS stock price today per share is 1590 INR.

How to purchase Hester Biosciences Limited stock?

You can buy HESTERBIO.NS shares on the NSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Hester Biosciences Limited?

The stock symbol or ticker of Hester Biosciences Limited is HESTERBIO.NS.

Which industry does the Hester Biosciences Limited company belong to?

The Hester Biosciences Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does Hester Biosciences Limited have in circulation?

The max supply of Hester Biosciences Limited shares is 8.51M.

What is Hester Biosciences Limited Price to Earnings Ratio (PE Ratio)?

Hester Biosciences Limited PE Ratio is 71.07733000 now.

What was Hester Biosciences Limited earnings per share over the trailing 12 months (TTM)?

Hester Biosciences Limited EPS is 22.37 INR over the trailing 12 months.

Which sector does the Hester Biosciences Limited company belong to?

The Hester Biosciences Limited sector is Healthcare.